Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for therapeutic peptides and oligonucleotides
3.2.1.2 Growing adoption of personalized medicine
3.2.1.3 Increasing outsourcing of manufacturing activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of manufacturing
3.2.2.2 Challenges related to quality control
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Peptide
5.3 Oligonucleotides
Chapter 6 Market Estimates and Forecast, By Service Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Contract manufacturing
6.3 Contract development
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Therapeutics
7.3 Diagnostics
7.4 Research
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical companies
8.3 Biopharmaceutical companies
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Aurigene Pharmaceutical Services Ltd.
10.2 Bachem Group
10.3 CordenPharma International
10.4 Creative Peptides
10.5 Curia Global, Inc.
10.6 EUROAPI S.A.
10.7 Merck KGaA
10.8 PolyPeptide Group
10.9 STA Pharmaceutical Co. Ltd.
10.10 Sylentis, S.A.
